These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 24324644)
1. Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis. Feng Z; Zeng S; Wang Y; Zheng Z; Chen Z PLoS One; 2013; 8(12):e80890. PubMed ID: 24324644 [TBL] [Abstract][Full Text] [Related]
2. Comparison between teriparatide and bisphosphonates for improving bone mineral density in postmenopausal osteoporosis patients: A meta-analysis. Fan G; Zhao Q; Lu P; Chen H; Tan W; Guo W; Liu C; Liu J Medicine (Baltimore); 2020 Apr; 99(15):e18964. PubMed ID: 32282692 [TBL] [Abstract][Full Text] [Related]
3. Teriparatide versus bisphosphonates for treatment of postmenopausal osteoporosis: A meta-analysis. Yuan F; Peng W; Yang C; Zheng J Int J Surg; 2019 Jun; 66():1-11. PubMed ID: 30890377 [TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of bisphosphonates for osteoporosis or osteopenia in Crohn's disease: a meta-analysis. Guo Z; Wu R; Gong J; Zhu W; Li Y; Li N; Li J Dig Dis Sci; 2013 Apr; 58(4):915-22. PubMed ID: 23179146 [TBL] [Abstract][Full Text] [Related]
5. The effects of teriparatide and bisphosphonates on new fractures in postmenopausal women with osteoporosis: A protocol for systematic review and meta-analysis. Ouyang Y; Chen S; Wan T; Zheng G; Sun G Medicine (Baltimore); 2021 Feb; 100(7):e24839. PubMed ID: 33607854 [TBL] [Abstract][Full Text] [Related]
6. Patient satisfaction and efficacy of switching from weekly bisphosphonates to monthly minodronate for treatment and prevention of glucocorticoid-induced osteoporosis in Japanese patients with systemic rheumatic diseases: a randomized, clinical trial. Tamechika SY; Sasaki K; Hayami Y; Ohmura SI; Maeda S; Iwagaitsu S; Naniwa T Arch Osteoporos; 2018 Jun; 13(1):67. PubMed ID: 29904824 [TBL] [Abstract][Full Text] [Related]
7. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial. Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637 [TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials. Wang J; Yao M; Xu JH; Shu B; Wang YJ; Cui XJ Osteoporos Int; 2016 May; 27(5):1683-90. PubMed ID: 26733377 [TBL] [Abstract][Full Text] [Related]
9. Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. Palmer SC; Strippoli GF; McGregor DO Am J Kidney Dis; 2005 Apr; 45(4):638-49. PubMed ID: 15806466 [TBL] [Abstract][Full Text] [Related]
10. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Rodd C; Lang B; Ramsay T; Alos N; Huber AM; Cabral DA; Scuccimarri R; Miettunen PM; Roth J; Atkinson SA; Couch R; Cummings EA; Dent PB; Ellsworth J; Hay J; Houghton K; Jurencak R; Larché M; LeBlanc C; Oen K; Saint-Cyr C; Stein R; Stephure D; Taback S; Lentle B; Matzinger M; Shenouda N; Moher D; Rauch F; Siminoski K; Ward LM; Arthritis Care Res (Hoboken); 2012 Jan; 64(1):122-31. PubMed ID: 22213727 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials. Chen L; Wang G; Zheng F; Zhao H; Li H Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731 [TBL] [Abstract][Full Text] [Related]
12. Treatment of Glucocorticoid-Induced Osteoporosis with Bisphosphonates Alone, Vitamin D Alone or a Combination Treatment in Eastern Asians: A Meta-Analysis. Wang J; Li H Curr Pharm Des; 2019; 25(14):1653-1662. PubMed ID: 31218954 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Zoledronic Acid for Treatment of Postmenopausal Osteoporosis: A Meta-Analysis of Randomized Controlled Trials. Wang C Am J Ther; 2017; 24(5):e544-e552. PubMed ID: 26938765 [TBL] [Abstract][Full Text] [Related]
15. Effects of monthly intramuscular neridronate in rheumatic patients in chronic treatment with low-dose glucocorticoids. Benucci M; Saviola G; Baiardi P; Abdi-Ali L; Povino MR; Dolenti S; Campostrini L; Sacco S; Manfredi M; Rossini M Clin Exp Rheumatol; 2009; 27(4):567-73. PubMed ID: 19772786 [TBL] [Abstract][Full Text] [Related]
16. Alendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseases: A meta-analysis. Kan SL; Yuan ZF; Li Y; Ai J; Xu H; Sun JC; Feng SQ Medicine (Baltimore); 2016 Jun; 95(25):e3990. PubMed ID: 27336902 [TBL] [Abstract][Full Text] [Related]
17. Alendronate for the Treatment of Osteoporosis in Men: A Meta-Analysis of Randomized Controlled Trials. Xu Z Am J Ther; 2017; 24(2):e130-e138. PubMed ID: 27058577 [TBL] [Abstract][Full Text] [Related]
18. Comparative Efficacy of Alendronate upon Vertebral Bone Mineral Density and Fracture Rates in East Asians Versus Non-East Asians with Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis. Wang Y; Jia G; Song J; Kong X; Zhang W; Meng C Horm Metab Res; 2018 Oct; 50(10):738-746. PubMed ID: 30312984 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review. Melek J; Sakuraba A Clin Gastroenterol Hepatol; 2014 Jan; 12(1):32-44.e5. PubMed ID: 23981521 [TBL] [Abstract][Full Text] [Related]
20. Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis. Wu J; Zhang Q; Yan G; Jin X J Orthop Surg Res; 2018 Aug; 13(1):194. PubMed ID: 30071889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]